Related Experiment Video
Updated: Feb 16, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.7K
Recent advances in understanding and managing T-cell lymphoma
Jun Ho Yi1, Seok Jin Kim2, Won Seog Kim2
1Division of Hematology-Oncology, Department of Medicine, Chung-Ang University , Seoul, Korea, South.
F1000Research
|December 21, 2017
Summary
Peripheral T-cell lymphoma (PTCL) is rare and diverse, lacking clear treatment guidelines. Recent molecular advances offer new therapeutic insights for this challenging blood cancer.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Peripheral T-cell lymphoma (PTCL) is a group of rare and heterogeneous lymphoid malignancies.
- Lack of robust clinical trial data complicates therapeutic decision-making for PTCL patients.
- Significant progress in understanding PTCL biology has been made.
Purpose of the Study:
- To review recent advancements in the molecular subtyping of PTCL.
- To summarize current and emerging therapeutic strategies for PTCL.
- To highlight areas requiring further research in PTCL.
Main Methods:
- Comprehensive literature search of recent studies on PTCL.
- Analysis of molecular subtyping techniques and their clinical implications.
- Synthesis of data on treatment outcomes for various PTCL subtypes.
Main Results:
- Molecular subtyping has refined the classification of PTCL, revealing distinct biological entities.
- Novel targeted therapies and immunotherapies are showing promise in early-phase trials.
- Treatment landscape for PTCL is evolving, with a move towards personalized medicine.
Conclusions:
- Accurate molecular subtyping is crucial for guiding optimal PTCL treatment.
- Further clinical validation of novel therapeutic agents is essential.
- Continued research is needed to address unmet needs in PTCL management.
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:22T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K
01:27Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
01:20Special Features of Adaptive Immunity
3.5K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.5K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:23Cells of the Adaptive Immune Response
9.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.1K